BBLG
Bone Biologics
BBLG
BBLG
4 hedge funds and large institutions have $160K invested in Bone Biologics in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
4
Holders Change
+4
Holders Change %
–
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$93K |
| 2 |
2
Jane Street
New York
|
$37K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$30K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $93K | 33,461 | +33,461 | New |
|
|
2
Jane Street
New York
| $37K | 13,464 | +13,464 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $30K | 10,741 | +10,741 | New |
|
|
CFGS
4
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
5
UBS Group
Zurich,
Switzerland
| $0 | 85 | +85 | New |
|